Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2551]
Articles [106]
Editorials [3]
Conferences [83]
elearning [20]
FDA approves osimertinib as first line treatment for EGFRm NSCLC
FDA approves osimertinib as first line treatment for EGFRm NSCLC
An artificial mole as an early warning system
An artificial mole as an early warning system
Can a simple blood test rule out lung cancer?
Can a simple blood test rule out lung cancer?
Is whole-brain radiation still best for brain metastases from small-cell lung cancer?
Is whole-brain radiation still best for brain metastases from small-cell lung cancer?
AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer
AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer
AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC
AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC
AACR 2018: Combination therapy doubles survival in metastatic lung cancer
AACR 2018: Combination therapy doubles survival in metastatic lung cancer
AACR 2018: New liquid biopsy-based cancer model reveals data on deadly lung cancer
AACR 2018: New liquid biopsy-based cancer model reveals data on deadly lung cancer
AACR 2018: First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple cancers
AACR 2018: First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple...
Immunotherapy provides long-term survival benefit: Further evidence in lung cancer
Immunotherapy provides long-term survival benefit: Further evidence in lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation